737 results on '"Wisniewski T."'
Search Results
52. Cooperative State-Industry Stream Studies: Lower Fox River, Wisconsin
53. Organization of Cooperative State-Industry Stream Studies in Wisconsin
54. Commercial-Scale Operation of Turbine Aeration on Wisconsin Rivers
55. Commercial-Scale Stream Reaeration
56. Extended dq modeling of wound-rotor synchronous machines with dampers for transient analysis
57. Nerve growth factor metabolic dysfunction in Down's syndrome brains
58. Amyloid-beta immunisation for Alzheimer's disease
59. Non-Adherent Behaviour and Glycaemic Control in Patients with Type 2 Diabetes Treated with Insulin
60. Numerical modelling of transient heat and moisture transport in protective clothing
61. Validation of A New Hemophilia-Specific Burden Scale for Caregivers of Children With Hemophilia In The Us – The Hemophilia Associated Caregiver Burden Scale (Hemocabtm)
62. Development And Validation Of The Hemophilia-Specific Burden Scale For Caregivers Of Children With Hemophilia In The Us – The Hemophilia Associated Caregiver Burden Scale (Hemocabtm)
63. Budget impact analysis of factor replacement Therapy with Turoctocog Alfa in the treatment of Hemophilia A
64. Pain Functional Impairment and Quality of Life (P-FIQ): an assessment of reliability of five patient reported outcome (PRO) instruments in Adult People with Hemophilia (PWH)
65. PHS58 - Cost Of Treatment-Related Adverse Events (TRAES) In Second-Line (2l) Advanced Hepatocellular Carcinoma (AHCC): Match Adjusted Indirect Comparison (MAIC) Of Nivolumab And Regorafenib
66. Isolated avulsion fracture of the anterior tubercle of the atlas
67. PDB63 - Non-Adherent Behaviour and Glycaemic Control in Patients with Type 2 Diabetes Treated with Insulin
68. Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy
69. The Experience Of Caring For Children With Hemophilia: Cross-Sectional Study Of Caregivers In The United States
70. Associations between negative impact on employment or relationships and haemophilia treatment centre (HTC) and health care practioner utilisation: Global results from the haemophilia experiences, results and opportunities (HERO) study
71. Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G)
72. PMD81 Evaluation of Product Wastage From Modern Human Growth Hormone Administration Devices
73. REMOVED: P02-51 Product wastage from modern human growth hormone administration devices: A laboratory analysis
74. Health‐related quality of life in haemophilia patients with inhibitors and their caregivers
75. Looking at the Cost: Using Flow Analysis to Assess and Improve Chemical Production Processes
76. PSY20 Costs Associated With the Burden of Joint Pain in Hemophilia A and B Patients With and Without Inhibitors
77. PDB29 Budget Impact Analysis of Norditropin Versus Three Leading Market Growth Hormone Therapies
78. Patient/caregiver perceived benefits and barriers to elective orthopedic surgery (EOS) in patients with congenital hemophilia with inhibitors
79. Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis
80. Patient and Caregiver Practices and Perceptions Associated With Reconstitution and Storage of Recombinant Human Growth Hormone
81. PSY45 CHARACTERISTICS OF CAREGIVERS AND THEIR EXPERIENCE ASSOCIATED WITH CONGENITAL HEMOPHILIA OF INHIBITOR PATIENTS
82. PSY58 - Pain Functional Impairment and Quality of Life (P-FIQ): an assessment of reliability of five patient reported outcome (PRO) instruments in Adult People with Hemophilia (PWH)
83. PSY17 - Budget impact analysis of factor replacement Therapy with Turoctocog Alfa in the treatment of Hemophilia A
84. PRM79 - Development And Validation Of The Hemophilia-Specific Burden Scale For Caregivers Of Children With Hemophilia In The Us – The Hemophilia Associated Caregiver Burden Scale (Hemocabtm)
85. Risk factors for nausea and vomiting (NV) following highly or moderately emetogenic chemotherapy (HEC or MEC) in U.S. community oncology practice.
86. P104 Aprepitant treated patients were better able to maintain daily functioning compared to active control therapy after receipt of moderately emetogenic chemotherapy for the prevention of chemotherapy induced nausea and vomiting
87. P1-22 Effet de la vaccination par un dérivé du peptide Aβ, K6Aβ1-30, chez des microcèbes âgés
88. 3610 Healthcare utilization and treatment patterns among cutaneous T-cell lymphoma (CTCL) patients in the United Kingdom and Brazilb
89. 3604 AVOID: antiemetics for chemotherapy induced nausea and vomiting (CINV): a retrospectIve descriptive study, describing the use of aprepitant in Belgium
90. Induction of Toll-Like Receptor 9 Signaling as a Method for Ameliorating Alzheimer's Disease-Related Pathology
91. Amendments and Corrections: Testing for Homogeneity of a Binomial Series
92. PCN30 COST-EFFECTIVENESS OF APREPITANT IN PATINENTS RECEIVING ANTIEMETIC PROPHYLAXIS FOR HIGHLY EMETOGENIC CHEMOTHERAPY IN HUNGARY
93. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging
94. Another Statistical Solution of a Combinatorial Problem
95. ¿Es factible la vacunación contra la encefalopatía espongiforme transmisible?
96. P4–290: Immunization with Aβ derivatives in Microcebus murinus: A primate lemurian model of Alzheimer's disease
97. P.5.b.003 Assessing the effects of memantine in APP/PS1 transgenic mice by behavioural studies and ex vivo imaging of amyloid plaques using gadolinium labelled amyloid β peptides and μMRI
98. P1-3 Vaccination par des dérivés du peptide Aß chez un lémurien, le microcèbe
99. Therapeutics and Prion Disease: Can Immunisation or Drugs be Effective?
100. Genetic algorithm for optimization of inspection stations allocation in multi-product manufacturing systems.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.